In response to the disruptive effect of coronavirus disease 2019 (COVID-19) in cancer management in the Philippines, four cancer centers created a collaborative strategic action plan in cancer management and workflow. This was aligned with the position set by the Philippine Radiation Oncology Society (PROS) [@b0005], and Philippine Medical Society of Oncology (PSMO) [@b0010]. It consists of four phases: screening, evaluation, treatment/management and disposition. Each phase includes an algorithm and core domains namely patients, personnel, doctors and infrastructure/facility. Each domain and algorithm contain strategic steps on sustaining supplies of personal protective equipment (PPE), triage creation, health and well-being of personnel, teleconsultation, treatment and safety of patients, structural changes and COVID-19 testing.

Phase I shows the triage for presence or absence of COVID-19 based on exposure and symptoms. Phase II shows patient with COVID-19 exposure/symptom will be classified as no covid, suspect, probable and confirm [@b0015], while those without exposure/symptoms will proceed to the required treatment modality and be classified as new, ongoing and follow up. Phase III shows the treatment management process for those with confirmed COVID-19, and those who will proceed with chemotherapy or radiation therapy. Phase IV includes the disposition plan after intervention for confirmed COVID-19, and resumption of regular schedule for chemotherapy or radiation therapy for those without COVID-19 ([Fig. 1](#f0005){ref-type="fig"} ).Fig. 1Cancer center adaptive workflow during Covid-19.

Everyone will be screened at the triage area and will fill up a COVID-19 screening information record ([Fig. 2](#f0010){ref-type="fig"} ) based on the department of health (DOH) decision tool [@b0015]. Patient with respiratory symptoms, with history of close contact to COVID-19 positive patients, and with travel history to areas with high incidence of COVID-19 were not allowed to enter the cancer center. Evaluation will be done by the infectious control officer at the emergency room [@b0020].Fig. 2Cancer center quick COVID-19 screening information record form.

Only staff on duty, patients, and one relative were allowed inside the cancer center premises, and a physical distance of at least 1 meter apart is observed [@b0025]. No mask, no entry policy was implemented. Patients were instructed to bring their own alcohol or hand sanitizers, and blanket during treatment. Sanitation of treatment couch, and bed was done after every patient using proven sanitizers [@b0030].

Patient prioritization protocol for planning, and start of radiation therapy was based on the following case category [@b0035], [@b0040], [@b0045], [@b0050]:1.Urgent -- superior vena cava syndrome, cord compression, pain, bleeding, life threatening symptoms, brain metastases, and patients coming from remote places were scheduled on the same day or the day after consultation.2.Semi urgent -- colorectal, concurrent protocol, head and neck, cervical, and lung were scheduled two to seven days after consultation.3.Not urgent -- breast, prostate, endometrial, post-operative, skin, and asymptomatic brain were scheduled eight to ten days after consultation.

Patient prioritization for chemotherapy was based on tiered approach of the European Society of Medical Oncology categorized as high, medium and low priority [@b0055].

Walk-in and new patients were scheduled during the clinic hours of the attending oncologist. Physical check-up of patient was limited, and teleconsultation was encourage using the platform <https://doxy.me> [@b0060], [@b0065].

Patients classified as suspected/probable/confirmed COVID-19 will follow the infectious control committee protocol based on DOH-Philippine Society of Molecular and Infectious Diseases guidelines [@b0020]. Oncologist and referring physician will consider the risk for both patient and staff and decide the need to pursue chemotherapy or radiation therapy [@b0025], [@b0040], [@b0070]. IgM and IgG Rapid Diagnostic Test (RDT) was used as an initial test for COVID-19 because real time reverse transcription-polymerase chain reaction test (rRT-PCR) which is the gold standard for confirmation of COVID-19 is not readily available and accessible. Patient with negative RDT results but with significant symptoms must be re-tested using rRT-PCR [@b0020]. A dedicated nurse on full PPE will handle confirmed infected patients for chemotherapy in an isolation room with a separate entrance and exit. No relatives nor visitors will be allowed. In case radiation therapy maybe life-saving, COVID-19 patients will be the last one to be treated and/or on a separate machine if available. Otherwise, priority in delaying or stopping radiation therapy is considered.

Clinical staff, cashier, and coordinators reports on a skeletal force while administrative, marketing, human resources, and finance will work from home as part of the modified working shifts.

Limited supplies of PPE were outsourced and the rest comes from donations. Ultraviolet light was used to sanitize PPE and washing was done so they can be re-use. The prescribed suit specifications were:1.Administrative personnel wear surgical mask.2.Cashier and secretaries wear surgical mask and goggles/face shields.3.Radiation therapist, and nurses wear surgical mask/N95, gloves, goggles/face shield, hair cap, isolation gown/coverall, and shoe cover/booties. Separate PPE are use during CT planning and brachytherapy.4.Oncologist wear surgical mask/N95, isolation gown and goggles/face shield.

Depression anxiety & stress scale tool was used for mental health evaluation [@b0075]. Free meals, shuttle service, increased in hazard pay and weekly online meeting were provided to boost the morale of all personnel.

Modified treatment protocol for chemotherapy follows the PSMO recommendations [@b0010], [@b0080], and radiation therapy follows the PROS recommendations including hypofractionation regimen for certain cases [@b0005].

Chemotherapy and brachytherapy were transformed into sterile area. Transparent acrylic or plastic shield for the triage, reception, cashier and nursing area were constructed for protection between personnel and patient.

This collaborative cancer management strategic action plan and workflow attempts to answer the uncertainties of this pandemic despite faced with meager resources. It may guide cancer centers from developing countries on how to adapt during these current adversities. We recommend adopting the following in the contemporary normal period:1.Establish a triage with a screening tool for emerging and re-emerging infectious diseases.2.Mandatory COVID-19 testing for all personnel and patients.3.Structural changes to provide adequate spaces, natural ventilations, dedicated entrance and exits, and dressing room for staff.4.Acquisition of a second radiation therapy machine to accommodate patients that requires isolation.5.Wearing of protective suits as part of the standard of care.6.Digital advancements like remote planning and delivery of plan solutions, electronic patient information and teleconsultations.7.Create an infectious response team who will be trained in handling affected cancer patients.
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